Bioqube Ventures is a Europe-rooted VC with global reach, focused on therapeutics.
We invest with intent and support our portfolio teams through every key inflection point. More than investors, we are scientists, operators, and builders – helping structure, scale, and stand by our companies all the way.
Investing in Life. Delivering Impact.
Founded in 2015, Bioqube Ventures has backed and supported over 20 biotech companies, beginning with an incubation model on the Janssen Pharmaceutica R&D campus in Belgium. Early successes validated our hands-on investment approach and led to multiple high-value exits. With the launch of the Bioqube Factory Funds in 2020, we continue to expand our reach across Europe, the United States, and the rest of the world.
Built on a strong network of partners across the life sciences ecosystem, Bioqube combines capital with collaboration to build transformative healthcare companies. Our partners include Johnson & Johnson Innovation – JJDC, Genmab, and IQVIA, alongside institutional investors, regional development funds, and private investors. This blend of scientific insight and financial strength helps biotech innovators turn breakthrough science into lasting impact.
